期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Developments for collagen hydrolysates as a multifunctional antioxidant in biomedical domains
1
作者 guiya deng Ke Huang +7 位作者 Xianchao Jiang Kun Wang Zihao Song Yuchen Su Chengming Li Shuai Zhang Shiqi Wang Yaqin Huang 《Collagen and Leather》 EI CAS 2023年第3期1-21,共21页
Antioxidant collagen hydrolysates refers to the peptides mixture with antioxidant properties identified from hydrolyzed collagen.Due to its specific structural,biological and physicochemical properties,collagen hydrol... Antioxidant collagen hydrolysates refers to the peptides mixture with antioxidant properties identified from hydrolyzed collagen.Due to its specific structural,biological and physicochemical properties,collagen hydrolysates have been explored as a multifunctional antioxidant in the biomedical field.In this review,we summarize recent advances in antioxidant collagen hydrolysates development.Initially,the preparation process of antioxidant collagen hydrolysates is introduced,including the production and separation methods.Then the effects and the mechanisms of amino acid composition and collagen peptide structure on the antioxidant activity of collagen hydrolysates are reviewed.Finally,the applications of antioxidant collagen hydrolysates in biomedical domains are summarized,with critical discussions about the advantages,current limitations and challenges to be resolved in the future. 展开更多
关键词 Collagen hydrolysates ANTIOXIDANT PEPTIDES Biomedical applications
原文传递
Anti-osteoporosis properties of phosphorylated collagen peptidemagnesium chelates in osteoblast MC3T3-E1 cells and ovariectomized mice
2
作者 Chao Zhang Bowei Du +4 位作者 guiya deng Shuai Zhang Tengfei Yu Yuepeng Guan Yaqin Huang 《Chinese Medical Journal》 SCIE CAS 2024年第14期1762-1764,共3页
To the Editor:Postmenopausal osteoporosis is a typical bone metabolic disruption disease caused by estrogen deficiency,characterized by deteriorated bone structure,reduced bone mineral density(BMD),and thinned sclerot... To the Editor:Postmenopausal osteoporosis is a typical bone metabolic disruption disease caused by estrogen deficiency,characterized by deteriorated bone structure,reduced bone mineral density(BMD),and thinned sclerotin,which has troubled millions of menopausal women worldwide.[1]Additionally,estrogen deficiency is accompanied by oxidative stress and inflammation,thus causing the occurrence and deterioration of osteoporosis.[2]Conventional treatment options have limited efficacy and cannot meet the requirements of long-term treatment.[3]Therefore,in order to alleviate the problem of osteoporosis in human health,innovative strategies should explore the possibilities and alternatives to current ones.In this study. 展开更多
关键词 osteoporosis inflammation magnesium
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部